Protagonist Therapeutics, Inc. (PTGX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD

Add to watchlist

27.11

+1.32

(+5.12%)

At close: 04:00PM EDT

27.58

+0.47

(+1.73%)

After hours:

07:56PM EDT

Loading interactive chart…

GuruFocus.com
Protagonist Therapeutics Inc (PTGX) Surpasses Q1 Revenue Estimates with Strategic Collaborations
Comprehensive Analysis of Q1 2024 Earnings and Strategic Developments
Simply Wall St.
We Might See A Profit From Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Soon
With the business potentially at an important milestone, we thought we'd take a closer look at Protagonist...
GlobeNewswire
Turnstone Biologics Appoints William Waddill to its Board of Directors
SAN DIEGO, April 16, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing a differentiated approach to treat and cure patients with solid tumors by pioneering selected tumor-infiltrating lymphocyte (Selected TIL) therapy, today announced the appointment of industry veteran William Waddill to the Company’s Board of Directors. The Company also announced that Patrick Machado has stepped down as a member o